Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.74484 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.70773 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.70689 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.63288 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.64996 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.80228 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.7243 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.68402 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67281 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.69271 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.68965 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.67576 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.69913 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.70098 | 31 |